Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe history now shows recruitment is closed (no longer looking for participants). The revision note was updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check10 days agoChange DetectedA new revision tag, v3.5.5, has been added to the record history, replacing the previous v3.5.4. This indicates an update to the page's revision documentation without altering study data or content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe study record history shows a new revision labeled v3.5.4 as the latest version, while the prior v3.5.3 label is no longer listed.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s displayed software/UI revision label changes from v3.5.2 to v3.5.3, indicating a general platform update without altering the clinical trial record itself.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded revision v3.5.0 and deleted revision v3.4.3 from the study record history.SummaryDifference0.1%

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.